← Leaderboards
Fatma Sezen Meydan Marks
U.S. National Inst Diabetes/Digst/Kidney
$498,000
Attributed
$498,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2020–25$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$498,000 · 2
By mechanism
R00$498,000 · 1
FI2$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Phenotype”
- Leonard Freedman · Leidos Biomedical Research, Inc.$68,463,085
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$28,580,688
- Evan Z Macosko · Broad Institute, Inc.$28,218,682
- Badri N Vardarajan · University Of Miami School Of Medicine$23,982,327
Research focus
PhenotypeSingle MoleculeMessenger RnaPathway InteractionsQuality ControlRibosomesGenome-WideLinkNeurodevelopmentNeuronsProteinsBiological Adaptation To StressCellular StressRegulationDisease PhenotypeFragile X SyndromeHomeostasisKineticsComplexExperimental StudyNeurodevelopmental DisorderNeuronal DifferentiationCellsStudy Models
Grant awards (3)
Regulation of ribosome collisions during health, development and disease$249,000
R00 · FY2025 · GM · contact PI
Regulation of ribosome collisions during health, development and disease$249,000
R00 · FY2024 · GM · contact PI
Understanding genome-wide and single-molecule dynamics of colliding ribosomes during health and disease$0
FI2 · FY2020 · GM · contact PI